Colonic and Rectal Endoscopy



Fig. 15.1
Standard colonoscope 12.8 mm. Pediatric colonoscope 11.8 mm



From the structural point of view, the colonoscope is composed – from the outside inwards – of an outer cover of polymer which coats a stainless steel wire mesh, then of two metal spiral bands. This envelops the functional components of the endoscope which are represented by: four rods or angulation wires, the spiral metal wire of the variable stiffness system, two fiber-optic bundles for light transmission, the operative channel, a channel for air insufflation/lens cleaning, the auxiliary water-jet channel, and the electrical connection to the CCD (charge-coupled device).

The images collected by the CCD are processed by the central CPU and sent to the HD monitor. In recent years, the main manufacturers of endoscopes have introduced the so-called enhanced endoscopy or electronic chromoendoscopy that gives a greater contrast of microvascular structures through the use of a special optical filter that exploit the characteristics of the absorption spectrum of hemoglobin (NBI by Olympus) or by a computer-based processing (i-Scan by Pentax and FICE by Fujifilm), enabling in both cases a better definition of the identified lesions (Ginsberg et al. 2012).



3 Indications and Contraindications for Colonoscopy


Following ASGE 2012 guidelines (ASGE Standards of practice committee 2012), colonoscopy is generally indicated in the following circumstances:












































































Indications for colonoscopy

Indications not for colonoscopy

Contraindications for colonoscopy

Evaluation of an abnormality on barium enema or other imaging study that is likely to be clinically significant, such as a filling defect and stricture

Chronic, stable, irritable bowel syndrome or chronic abdominal pain; there are unusual exceptions in which colonoscopy may be done once to rule out disease, especially if symptoms are unresponsive to therapy

Fulminant colitis

Evaluation of unexplained GI bleeding:

 Hematochezia

 Melena after an upper GI source has been excluded

 Presence of fecal occult blood

Acute diarrhea

Documented acute diverticulitis

Unexplained iron-deficiency anemia

Metastatic adenocarcinoma of unknown primary site in the absence of colonic signs or symptoms when it will not influence management
 

Screening and surveillance for colonic neoplasia:

 Screening of asymptomatic, average-risk patients for colonic neoplasia

 Examination to evaluate the entire colon for synchronous cancer or neoplastic polyps in a patient with treatable cancer or neoplastic polyp

 Colonoscopy to remove synchronous neoplastic lesions at or around the time of curative resection of cancer followed by colonoscopy at 1 year and, if normal, then 3 years and, if normal, then 5 years thereafter to detect metachronous cancer

 Surveillance of patients with neoplastic polyps

 Surveillance of patients with a significant family history of colorectal neoplasia

Routine follow-up of inflammatory bowel disease (except for cancer surveillance in chronic ulcerative colitis and Crohn’s colitis)
 

For dysplasia and cancer surveillance in select patients with long-standing ulcerative or Crohn’s colitis

GI bleeding or melena with a demonstrated upper GI source
 

Clinically significant diarrhea of unexplained origin
   

Intraoperative identification of a lesion not apparent at surgery (e.g., polypectomy site, location of a bleeding site)
   

Treatment of bleeding from lesions such as vascular malformation, ulceration, neoplasia, and polypectomy site
   

As an adjunct to minimally invasive surgery for the treatment of diseases of the colon and rectum
   

Management or evaluation of operative complications (e.g., dilation of anastomotic strictures)
   

Foreign body removal
   

Excision or ablation of lesions
   

Decompression of acute megacolon or sigmoid volvulus
   

Balloon dilation of stenotic lesions (e.g., anastomotic strictures)
   

Palliative treatment of stenosing or bleeding neoplasms (e.g., laser, electrocoagulation, stenting)
   

Marking a neoplasm for localization
   


4 Informed Consent and Risk Assessment


Informed consent must be obtained from the patient before performing the procedure. It must be a clear discussion about risks, benefits, and alternative to the procedure. Common risks of colonoscopy such as perforation, bleeding, infections, sedation-related adverse events, missed lesions, and intravenous site adverse events must be discussed. If an operative procedure is planned, the patient must be informed about the specific risks related to the scheduled procedure.


5 Management of Patients Under Anticoagulant and/or Antiplatelet Agents Therapy


The management of patients under therapy with anticoagulant and/or antiplatelet agents before and after an endoscopic operative procedure must be carefully evaluated. In order to decide whether to continue or discontinue these therapies it’s critical to stratify the risk continue or discontinue these therapies is fundamental the stratification of the risk of bleeding of the endoscopic procedure scheduled and the risk of a thromboembolic event related to interruption of these drugs in accord with the patient’s consultant (e.g., cardiologist/neurologists) or treating physician.

The anticoagulants include: warfarin, heparin, low molecular weight heparins (LMWH), and, more recently, the new direct-acting oral anticoagulants (DOAC).

The antiplatelet agents (APA) are aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), thienopyridines (e.g., clopidogrel, prasugrel, and ticlopidine), and inhibitors of the receptor GPIIb/IIIa.

Recommendations of ASGE/ESGE (Boustière et al. 2011; ASGE Standards of Practice Committee 2009) are summarized in Table 15.1.


Table 15.1
Management of patients on anticoagulant and/or antiplatelet drugs undergoing endoscopies procedures























 
Risk of thromboembolic event

Low-risk condition

High-risk condition

Procedure risk for bleeding

Low-risk procedures

 Diagnostic colonoscopy ± biopsies

 Colonic polypectomy < 1 cm

 Digestive stenting

 Maintain APA therapy

 Maintain aspirin

 Discontinue thienopyridines

 Discontinue warfarin

 Maintain dual APA therapy

 Maintain warfarin or considering bridging therapy with LMWH

High-risk procedures

 Colonic polypectomy ≥1 cm

 EMR

 ESD

 Stop aspirin 5–7 days

 In patients taking a thienopyridine alone, it is recommended to substitute with aspirin

 Discontinue warfarin and considering bridging therapy with LMWH

 Maintain aspirin

Discuss temporary cessation of:

 Clopidogrel, 5–7 days

 Prasugrel, 7–10 days

Or consider postponing procedure to time when thromboembolic risk is low

Discontinue warfarin and considering bridging therapy with LMWH


APA antiplatelet agents

EMR endoscopic mucosal resection

ESD endoscopic submucosal dissection

LMWH low molecular weight heparins


6 Bowel Preparation for Colonoscopy


Bowel preparation is crucial for the outcome of colonoscopy and for a high-quality examination, improving adenoma detection rate and reducing costs, lowering the rate of rescheduled examinations due to inadequate preparation (Harewood et al. 2003; Froehlich et al. 2005; Rex et al. 2002b).

Some endoscopists prescribe a low-fiber diet during the 3 or 5 days preceding colonoscopy, but the benefits of this diet have not been well assessed. Based on literature data, a low-fiber diet the day before the examination seems to be enough. In order to reduce the presence of bubbles and foam, which are frequently encountered during colonoscopy (32 %–57 % of patients), the addition of simethicone to the bowel preparation is useful, which reduces the surface tension of air bubbles and improves endoscopic view (Hassan et al. 2013; Tongprasert et al. 2009; Shaver et al. 1988).

Actually the three widely accepted bowel preparations for colonoscopy are:



  • Polyethylene glycol (PEG)-based solutions : this is the first osmotically balanced solution; it is an inert, nonfermentable, nonabsorbable polymer, which does not induce fluid or electrolyte absorption or secretion. For this reason, it is safe and could be used in patients with comorbidities as liver, heart, or kidney failure. It is associated with a good cleansing efficacy, but approximately 19 % of patients are unable to complete the preparation because of its large volume (4 L) and unpalatable taste. A “low-dose” 2 L PEG (MoviPrep, Norgine in Europe and Australia, Salix Pharmaceuticals in the USA) was recently developed. This reduced volume solution has the same safety, almost the same efficacy, and is better tolerated than “high-dose” PEG (Jansen et al. 2011; Ell et al. 2008).


  • Sodium phosphate-based solutions : this is a smaller volume preparation, which acts by exerting an hyperosmotic effect and by stimulating stretch receptors to increase peristalsis. This preparation has been shown to be equally effective and better tolerated than PEG. Sodium phosphate preparations must be used carefully because they have the potential to cause electrolyte disturbances including serious hyperphosphatemia and hypocalcemia. For this reason, this preparation is not recommended in elderly, in patients with heart, renal, and liver failure and other electrolyte imbalances. Also, this preparation should be avoided in patients with possible inflammatory bowel disease because it could cause colonic inflammation and aphthous ulcerations in 25 % of cases, which is less common in patients using PEG (2–3 %). ESGE suggest that oral sodium phosphate can only be advised in selected cases of specific needs that cannot be met by an alternative product (Hassan et al. 2013).

Sulfate-based solutions: magnesium is a well-known traditional laxative which increases water in the gastrointestinal tract and stimulates peristalsis. A combination of magnesium sulfate and sodium picosulfate (Picoprep or Citrafleet) was compared with PEG and sodium phosphate-based solutions in a meta-analysis showing that PEG provided a satisfactory colon cleansing in a similar proportion of patients, with less adverse events such as nausea, vomiting, or abdominal pain, but sodium phosphate produced better cleansing than magnesium sulfate and sodium picosulfate (Tan and Tjandra 2006). An adequate oral intake of water during preparation is essential. Given the potential for dehydration and dangerous hypermagnesemia, this combination is relatively contraindicated in the presence of congestive cardiac failure and impaired renal function.

Other nonabsorbable sugars like mannitol, sorbitol, and lactulose are ineffective and must be avoided because they may be metabolized by colonic bacteria carrying the risk of colonic explosion during procedures requiring electrosurgery.


6.1 Timing of Bowel Preparation


Many RCT have shown that timing of bowel preparation is very important in order to obtain a good cleansing efficacy. “Split” dose of cathartic half the day before and half the day of the examination, or a same-day regimen (for afternoon colonoscopy), improves significantly the effect of colonic cleansing. “Split” regimen is better tolerated against the single dose. Finally, for better results, the preparation should end 6–4 h before starting the examination (Marmo et al. 2010; Parra-Blanco et al. 2006; Varughese et al. 2010; Matro et al. 2010; Longcroft-Wheaton and Bhandari 2012; Eun et al 2011; Siddiqui et al. 2009).

ASGE/ACG recommend that examination should be considered adequate if it allows detection of polyps >5 mm in size (Rex et al. 2002b). Quality of bowel preparation must be documented in each colonoscopy report. Validated preparation scores, such as Boston (Calderwood and Jacobson 2010) or Ottawa bowel preparation (Rostom and Jolicoeur 2004) score, should be used.


7 Sedation in Colonoscopy


Sedation and analgesia are usually recommended in order to improve examination quality, reduce procedure time, and minimize discomfort during colonoscopy. The reasons to use sedation and analgesia during colonoscopy are the possible pain caused by the procedure and patient’s anxiety. The level of sedation can be generally considered on a spectrum from no sedation to general anesthesia. The choice of the level of sedation depends on patient comorbidities, complexity of the procedure, discomfort expected or experienced, and availability or unavailability of the anesthesiologist. All patients that undergo colonoscopy must be under continuous monitoring before, during, and after sedation with pulse oximetry and for high-risk patients with hemodynamic measurements and continuous electrocardiogram.

The level of sedation most frequently used is conscious sedation that could be reached using benzodiazepines and centrally acting narcotic opioids, such as meperidine or fentanyl. This sedation aims at maintaining the patient’s collaboration for all the time requested to complete the procedure with drug-induced depression of consciousness, during which the patient responds purposefully to verbal commands, either alone or accompanied by light tactile stimulation. Usually the patient breathes spontaneously, without assisted ventilation. Oversedation, hypoventilation, aspiration, and airway obstruction are the most commonly reported sedation-related complications (Freeman 1994; Benjamin 1996). Elderly patients and subjects with compromised renal and hepatic functions may be at a greater risk of adverse events. One advantage of the use of conscious sedation with benzodiazepine and opioids is the possibility, in case of oversedation or in the presence of adverse event, to use narcotics and benzodiazepines antagonists such as naloxone and flumazenil. Conscious sedation does not require the presence of an anesthesiologist, but the endoscopist must be well trained in the management of complications of sedative drugs. After colonoscopy patients must be monitored in a recovery room for 30–60 min and can return to normal activities on the next day.

Some endoscopists perform unsedated colonoscopy in order to reduce the risk of sedation-related complications and costs, but the pain associated with colonoscopy can affect the quality of the examination and the patient’s compliance. It has been demonstrated that for unsedated colonoscopy, the experience of the endoscopist is fundamental. Recently, to reduce pain of scope insertion caused by stretching of intestinal wall, carbon dioxide (CO2) insufflation, water immersion (WI), and water exchange (WE) techniques have been proposed.



  • CO2 insufflation is readily absorbed causing less wall tension.


  • Water-assisted colonoscopy is performed using water infusion and aspiration during insertion of the instrument (WE) or during withdrawal (WI).

Many studies on colonoscopy insertion demonstrated that WI and WE techniques reduce insertion pain when compared to air or CO2 insufflation. The least painful technique was WE with increased completion of unsedated colonoscopy (Hsieh et al. 2014; Amato et al. 2013; Bretthauer 2010; Garborg et al. 2015).

For painful or prolonged procedures or for patients intolerant to colonoscopy under conscious sedation, deep sedation based on the use of propofol, a hypnotic drug, is commonly used. Deep sedation is defined as a drug-induced depression of consciousness, during which the patient cannot be easily aroused but responds purposefully to repeated or painful stimulations. Patient’s spontaneous ventilation is usually maintained, but sometimes ventilation assistance may be required. Deep sedation with propofol during colonoscopy is associated with improved patient’s and physician’s satisfaction, because of its rapid onset and action (induces sedation within 30–60 s), its amnesic properties, and its short context-sensitive half-life of 2–8 min. For these reasons, it is considered an attractive drug for colonoscopy. Propofol can be administrated as monotherapy or in a combination with opioids and benzodiazepine. When used in combination, total dose of propofol can be reduced. Propofol may cause respiratory depression, apnea, or hypotension. Moreover, in 14 % of patients tremors, twitches, hypertonus, and hiccups can occur. Pulmonary edema, hypertension, cardiac arrhythmias, bronchospasm, or laryngospasm happens more rarely. For this reason, monitoring and managing the airway and breathing is more critical and requires the presence of anesthesiologists with additional costs.


8 Quality Indicators for Colonoscopy


Quality indicators for colonoscopy (Rex et al. 2015) are summarized in Table 15.2.


Table 15.2
Quality indicators for colonoscopy
































Pre-procedure

Intra-procedure

Post-procedure

Appropriate indications

Correct administration of sedation

Incidence of perforation for all examination (<1:500)

Informed consent and risk assessment

Cecal intubation identifying cecal landmarks (appendiceal orifice and ileocecal valve with photo-documentation) and a detailed mucosal inspection

Incidence of perforation for screening examination (<1:1000)

Correct management of antithrombotic drugs

Quality of bowel preparation documentation

Incidence of postpolypectomy bleeding (<1 %). The risk of bleeding increases with polyp size; for polyps >2 cm of diameter, bleeding rates may exceed 10 %

Sedation plan

Frequency of adenoma detection rate (ADR), that is, the primary measure of the quality of mucosal inspection and the single most important quality measure in colonoscopy

Appropriate recommendation for timing of repeat colonoscopy after histologic findings is reviewed

Timeline of procedure

Withdrawal time >6 min is demonstrated in several studies that increase ADR



9 T echnique of Colonoscopy


For a high-quality colonoscopy, it is essential to refer to the correct principles of technique. This is essential not only to improve the technical quality of the examination but also to eliminate or minimize visceral pain during the exam. Basic rules of colonoscopy involve proper anterograde push of colonoscope, precise movements of the tip, constant identification of the bowel lumen, appropriate twist on the instrument’s longitudinal axis, and controlled suction.

The discomfort caused by colonoscopy is mostly dependent by the stretching of the mesenteric supports of the colon and, to a lesser extent, by the distension due to the air blown in the colon. Elder patients are more tolerant of the curves and twists caused by the colonoscope because the elasticity of the mesentery rises with age, while women, due to the lower abdominal area in which the colon and the angle are located that the sigmoid presents between the uterus and left inguinal area, are generally subject to more frequent traction and straightening of the mesentery, resulting in increased tenderness.

Despite the considerable individual variability, definitely the presence of loops causes pain. That is why this examination, according to a correct technique based on frequent retraction movements, aims to keep the endoscope as straight as possible, reducing the probability of marked tenderness.

Colonoscopy may be conducted by only one endoscopist that holds the instrument with his right hand, while his left hand handles the controllers on the chassis, or the doctor who commands with both hands grips the endoscope and the assistant (usually the nurse) that pushes and rotates the instrument. Most experts believe that the first option is preferable because it allows you to have a greater sensitivity about the thrust force applied, and it allows you to correct any loops as well as greater readiness to overcome difficult stretches as stenosis, particularly curves angled or rigid segments with greater caution. Only in certain moments, which require mandatory concurrent use of both knobs, the instrument is held by the assistant.

Most endoscopists use the left lateral decubitus position as a start position for the colonoscopy, although some prefer the supine position and very few the right side. A careful inspection of the perianal region and a digital exploration of the rectum should precede the introduction of the colonoscope. This procedure allows a lubrication of the anal canal, the evaluation of the sphincter tone, and the exclusion of pathological conditions such as the presence of fistulous orifices, leakage of secretions or blood, presence of palpable stenosis, etc. The colonoscope is then inserted through the anus gently holding it at about 10 cm from the tip.

Once distended the distal rectum by inflation and aspirated residues, a retroflection maneuver should be performed carefully to inspect the rear portion of the mucosa immediately above the dentate line as small lesions at this level cannot be detected in front view only. The left lateral decubitus position is more favorable to give a great exposure of the distal rectum. The rear view is performed by angling to the maximum the tip of the colonoscope while it is introduced and displacing it gently sliding along one of the side walls so turning the optics toward the internal anal orifice. This maneuver can easily lead to traumatic injuries of the mucosa and should be done with caution. If the operator encounters difficulties during the retroversion of the instrument, it is good practice to desist in order to avoid complications and observe carefully the distal rectum by front view only.

Once the rectum is explored, the progression through the sigmoid colon, the descending colon, and the splenic flexure is probably the most delicate moment of the procedure and is usually being associated with the formation of loops and onset of pain. The endoscope is advanced using a minimum thrust associated with slight movements of clockwise and counterclockwise torque impressed to the instrument by endoscopist’s right hand. This avoids having to use too often the right/left knob and makes the insertion more fluid. The direction of the intestinal lumen can be identified thanks to some details such as folds convergence, presence of a less illuminated or “shadow” area on the visual field, the observation of transverse haustral folds and small translucent interhaustral lines, or the identification of a single longitudinal fold introflexed in the lumen formed by one of the three taeniae coli. For each curve, it is necessary to exactly locate the direction of the lumen and preferentially rotate the instrument positioning the tip in the upper part of the visual field (12 h). The tip must be angulated and slightly anticipating the thrust movement. If the lens is found in direct contact with the mucosa, it is essential to retract the instrument until the lumen is seen again, identifying the right lumen direction.

Some sigmoid corners are angled to the point that their overcoming must be performed “blindly.” In these cases, the endoscopist must be extremely confident on the lumen direction and should push the endoscope using gradually the maximum angulation of the tip. During this maneuver, small translations from the axis of the curve must be corrected by locating mentally the lumen direction and consequently turning the instrument. After having passed a good part of the curve, a full rotation of the right/left knob can be associated to increase the angle of the tip and to facilitate the transition.

To aspirate residual fluids, it is convenient to place them at 6 o’clock position and aspirate while blowing air, thus preventing complete collapse of the bowel wall and unwilling suctions of the mucosa.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2017 | Posted by in ABDOMINAL MEDICINE | Comments Off on Colonic and Rectal Endoscopy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access